Inflammasome pathway in kidney transplantation

Area of Science:

• Immunology
• Nephrology
• Transplantation

Background:

• Kidney transplantation offers superior outcomes to dialysis for end-stage kidney disease.
• Long-term graft survival remains a challenge, with nearly 50% of transplants failing within 15-20 years.
• Graft loss is often driven by immune-inflammatory processes.

Purpose of the Study:

• To review the role of inflammasome activation in kidney transplant complications.
• To highlight the current understanding of inflammasome pathway deregulation in post-transplant settings.
• To identify inflammasome regulation as a potential therapeutic target.

Main Methods:

• Literature review of research on inflammasome pathways in kidney transplantation.
• Analysis of studies linking inflammasome activation to post-transplant complications.
• Synthesis of current knowledge on inflammasome biology in transplant recipients.

Main Results:

• The inflammasome (NLRP3, NLRP1, NLRC4, AIM2) plays a key role in immune responses to pathogens and host-derived molecules.
• Deregulation of inflammasome pathways is implicated in major post-transplant complications.
• Mechanisms of inflammasome activation in ischemia-reperfusion injury, rejection, and infections are not fully understood.

Conclusions:

• Inflammasome activation is a significant factor in kidney transplant failure.
• Further research is needed to elucidate the precise mechanisms of inflammasome involvement.
• Targeting inflammasome pathways may offer novel therapeutic strategies for enhancing long-term graft survival.